These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 20231680

  • 1. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
    Ammann RA, Bodmer N, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, Kühne T, Popovic MB, Lüthy AR, Aebi C.
    J Clin Oncol; 2010 Apr 20; 28(12):2008-14. PubMed ID: 20231680
    [Abstract] [Full Text] [Related]

  • 2. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Agyeman P, Aebi C, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, Kühne T, Beck Popovic M, Leibundgut K, Bodmer N, Ammann RA.
    Pediatr Infect Dis J; 2011 Jul 20; 30(7):e114-9. PubMed ID: 21394050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
    Rondinelli PI, Ribeiro Kde C, de Camargo B.
    J Pediatr Hematol Oncol; 2006 Oct 20; 28(10):665-70. PubMed ID: 17023827
    [Abstract] [Full Text] [Related]

  • 5. Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Lüthi F, Leibundgut K, Niggli FK, Nadal D, Aebi C, Bodmer N, Ammann RA.
    Pediatr Blood Cancer; 2012 Jul 15; 59(1):90-5. PubMed ID: 21837771
    [Abstract] [Full Text] [Related]

  • 6. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
    Wicki S, Keisker A, Aebi C, Leibundgut K, Hirt A, Ammann RA.
    Pediatr Blood Cancer; 2008 Dec 15; 51(6):778-83. PubMed ID: 18726920
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
    Ammann RA, Hirt A, Lüthy AR, Aebi C.
    Pediatr Infect Dis J; 2004 Jan 15; 23(1):61-7. PubMed ID: 14743049
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study.
    Lavieri L, Koenig C, Bodmer N, Agyeman PKA, Scheinemann K, Ansari M, Roessler J, Ammann RA.
    Pediatr Blood Cancer; 2021 Dec 15; 68(12):e29253. PubMed ID: 34310027
    [Abstract] [Full Text] [Related]

  • 12. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ, Aebi C, Otth M, Leibundgut K, Hirt A, Ammann RA.
    Pediatr Infect Dis J; 2007 Nov 15; 26(11):989-94. PubMed ID: 17984804
    [Abstract] [Full Text] [Related]

  • 13. Predictive Indicators to Identify High-Risk Paediatric Febrile Neutropenia in Paediatric Oncology Patients in a Middle-Income Country.
    Green LL, Goussard P, van Zyl A, Kidd M, Kruger M.
    J Trop Pediatr; 2018 Oct 01; 64(5):395-402. PubMed ID: 29149345
    [Abstract] [Full Text] [Related]

  • 14. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E, Bodmer N, Simon A, Leibundgut K, Kühne T, Niggli FK, Ammann RA.
    Pediatr Blood Cancer; 2012 Sep 01; 59(3):423-30. PubMed ID: 22271702
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic risk factors for serious complications in an inpatient population with neutropenia at the onset of a febrile episode].
    Gómez Roca C, Rivero M, Hugo K, Novillo A, Marta Lapadula M, Recondo G, Milberg M.
    Medicina (B Aires); 2006 Sep 01; 66(5):385-91. PubMed ID: 17137166
    [Abstract] [Full Text] [Related]

  • 16. Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia?
    Oguz A, Karadeniz C, Ckitak EC, Cil V.
    Pediatr Hematol Oncol; 2006 Mar 01; 23(2):143-51. PubMed ID: 16651243
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.